Description
The mHealth services dominated the market in 2014 and are expected to grow over $55.63 billion by the end of the forecast period due to the increasing usage of mHealth solutions by healthcare providers and pharmaceutical companies along with end users (patients). However, device segment is expected to grow in near future with a high CAGR of 38.02%, from 2015 to 2022, due to increasing integration of mHealth devices with smart phones and weareables, and also, increasing opportunities of connected health solutions are predicted to promote the growth of this market through the forecast period.
Mobile health (mHealth) is one of the most modernized trends in the healthcare industry that has shown tremendous progress in the last few years. This trend is observed due to the flourishing growth of personal health devices, which can be easily worn or used with a smartphone or tablet. Mobile Health refers to the use of mobile communications, such as personal digital assistant (PDAs), laptops, and mobile phones among others, for health services and information.
The study includes an analysis of therapeutics and applications in which mHealth is used, in addition to the market study of the mHealth devices and services used across different geographical regions. The study presents a detailed analysis of the mHealth ecosystem (devices and services), therapeutics, applications, and geography along these lines: market size, drivers, growth opportunities, and challenges. The major end-use application areas of mHealth devices and services with respect to the market size and growth rate has also been identified and discussed in the report.
Key question answered in the report:
• What are the major market drivers, challenges and opportunities of the mHealth market and their use cases?
• Which factors will be driving the market through the forecast period?
• What factors are currently challenging the mHealth industry?
• What are the use cases and key platforms to deliver the services of each application?
• What are the key developmental strategies in different applications across all regions?
• How will the key market players leverage on key developments such as Mergers and Acquisitions, Partnerships, and Product Launch among others?
• Which compliances and certifications are necessary to make a product acceptable?
• Which geographical region will lead the global mHealth market by the end of the forecast period?
• Who are the key players in the mHealth market?
Table of contents
1 REPORT SCOPE
1.1 SCOPE OF THE STUDY
1.1.1 MOBILE HEALTH (MHEALTH): REPORT COVERAGE
1.1.2 BIS RESEARCH METHODOLOGY
1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL MARKET STUDY
1.1.3.1 GEOGRAPHICAL ANALYSIS
1.1.3.2 DEMAND SIDE & SUPPLY SIDE ANALYSIS
1.1.3.3 DATA SYNTHESIS & BRIDGING
1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): RESEARCH METHODOLOGY
1.1.5 KEY DATA POINT SOURCES
1.1.5.1 DATA POINTS TAKEN FROM SECONDARY SOURCES
1.1.5.2 DATA POINTS TAKEN FROM PRIMARY SOURCES
1.1.6 REPORT DESCRIPTION
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 MARKET DRIVERS
3.2.1.1 PATIENTS INVOLVEMENT IN PERSONAL HEALTHCARE
3.2.1.2 PROLIFERATION OF SMARTPHONES AND WEARABLE DEVICES INTO HEALTHCARE
3.2.1.3 INTEGRATION OF WIRELESS TECHNOLOGIES WITH PORTABLE HEALTHCARE DEVICES
3.2.1.4 INTRODUCTION OF CONNECTED HEALTHCARE SOLUTIONS IN THE MHEALTH MARKET
3.2.1.5 BENEFITS OF COST EFFECTIVENESS AND PATIENTS’ CONVENIENCE
3.2.1.6 INCREASE IN LIFESTYLE DISEASE
3.2.2 MARKET CHALLENGES
3.2.2.1 LOW RATE OF LITERACY AND LANGUAGE BARRIERS IN LOW- AND MIDDLE-INCOME COUNTRIES (LMICS)
3.2.2.2 INVASION OF PRIVACY
3.2.2.2.1 SECURITY BREACH CASES
3.2.2.2.2 POTENTIAL RISK OF HARDWARE OR SOFTWARE FAILURE
3.2.2.2.3 STRINGENT REGULATIONS AND STANDARDS
3.2.2.2.4 LACK OF AWARENESS ABOUT THE POSSIBLE APPLICATIONS OF MHEALTH
3.2.3 MARKET OPPORTUNITIES
3.2.3.1 PARTNERSHIP: AN ENTRY MODE
3.2.3.2 INTRODUCTION OF MHEALTH IN DEVELOPING ECONOMIES
4 INDUSTRY DYNAMICS
4.1 MHEALTH MARKET TIMELINE
4.2 VALUE CHAIN OF THE MHEALTH MARKET
4.2.1.1 DEVICE MANUFACTURERS
4.2.1.2 APP DEVELOPERS
4.2.1.3 NETWORK PROVIDERS/ MOBILE OPERATORS
4.2.1.4 HEALTHCARE PROVIDERS AND PHARMACEUTICALS
4.2.1.5 PATIENTS
4.2.1.6 CONSORTIUMS, CERTIFICATION, REGULATIONS, & STANDARDS
4.2.1.6.1 INTRODUCTION
4.2.1.6.2 CONSORTIUMS
4.2.1.6.3 ALLIANCE/ASSOCIATIONS
4.2.1.6.4 REGULATORY BODIES
4.2.1.7 FOOD AND DRUG ADMINISTRATION (FDA)
4.2.1.8 MEDICAL DEVICE REGULATION ACT
4.2.1.9 MEDICAL MOBILE APPLICATION(MMA)
4.2.2 CERTIFICATION
4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE ANALYSIS
4.2.4 BARGAINING POWER OF BUYER
4.2.5 BARGAINING POWER OF SUPPLIER
4.2.6 THREAT FROM SUBSTITUTE
4.2.7 THREAT FROM A NEW ENTRANT
4.2.8 INTENSITY OF COMPETITIVE RIVALRY
5 GLOBAL MHEALTH MARKET ECOSYSTEM
5.1 INTRODUCTION
5.1.1 MHEALTH DEVICES
5.1.2 MEDICAL DEVICES
5.1.2.1 SMBG MONITOR
5.1.2.1.1 SMBG DEVICE TYPES& USES
5.1.2.1.2 DISEASES MANAGED BY SMBG DEVICE
5.1.2.1.3 KEY PLAYERS
5.1.2.2 BLOOD PRESSURE (BP) MONITOR
5.1.2.2.1 BP MONITOR DEVICE TYPES & USES
5.1.2.2.2 DISEASES MANAGED BY BP MONITOR DEVICE
5.1.2.2.3 KEY PLAYERS
5.1.2.2.4 PULSE OXIMETER
5.1.2.2.5 PULSE OXIMETER : TYPES & USES
5.1.2.2.6 DISEASES MANAGED BY PULSE OXIMETER DEVICE
5.1.2.2.7 KEY PLAYERS
5.1.2.3 CARDIAC MONITORS
5.1.2.3.1 DISEASES MANAGED BY CARDIAC MONITORS
5.1.2.3.2 DISEASE MANAGEMENT DEVICES TYPES
5.1.2.3.3 CARDIAC MONITOR USES
5.1.2.4 KEY PLAYERS
5.1.2.5 OTHER MEDICAL DEVICES
5.1.2.5.1 HEALTH AND FITNESS DEVICES
5.1.2.5.2 HAND WORN PRODUCTS
5.1.2.5.2.1 SMART WATCH
5.1.2.5.2.2 WRIST WEAR
5.1.2.5.3 KEY PLAYERS
5.1.2.5.4 HEAD WORN PRODUCTS
5.1.2.5.4.1 AR/VR HMD/HUD
5.1.2.5.4.2 OTHERS
5.1.2.5.4.3 BODY WORN PRODUCTS
5.1.2.5.4.4 SMART TEXTILE
5.1.2.5.4.5 WEARABLE PATCH
5.1.2.5.4.6 OTHERS
5.1.2.5.5 NON-CLINICAL APPLICATIONS
5.1.2.5.6 CLINICAL APPLICATION
5.1.2.6 OTHERS DEVICES
5.1.2.6.1 MOBILE TELEMEDICINE/TELE-CARE DEVICES
5.1.2.6.2 HOME CARE DEVICES
5.1.2.6.2.1 VESSYL
5.1.2.6.2.2 TAO
5.1.2.6.2.3 CUBESENSORS
5.1.2.6.2.4 KOLIBREE
5.1.2.6.2.5 TELLSPEC
5.1.2.6.2.6 KINSA
5.1.2.6.2.7 BEDDIT
5.1.2.6.2.8 WELLO IPHONE CASE
5.1.2.6.3 KEY PARTICIPANTS
5.1.2.7 MHEALTH SERVICES
5.1.3 MOBILE HEALTH APPS AND CONTENT SOLUTION
5.1.3.1 SOFTWARE
5.1.3.2 BIG DATA
5.1.3.3 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
5.1.3.3.1 MARKET TRENDS AND MARKET DEVELOPMENTS
5.1.3.3.2 KEY PARTICIPANTS
5.1.4 NETWORK AND SERVICES/ MOBILE OPERATORS
5.1.4.1 BENEFITS OF NETWORK & SERVICES
5.1.4.2 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
5.1.4.2.1 MARKET TRENDS AND MARKET DEVELOPMENTS
5.1.4.2.2 KEY PARTICIPANTS
5.1.5 HEALTHCARE AND PHARMACEUTICALS
5.1.5.1 HEALTHCARE PROVIDERS
5.1.5.2 PHARMACEUTICALS
5.1.5.2.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
5.1.5.2.1.1 MARKET TRENDS AND MARKET DEVELOPMENTS
5.1.5.2.1.2 KEY PARTICIPANTS
6 GLOBAL MHEALTHMARKET – THERAPEUTICS
6.1 INTRODUCTION
6.1.1 GLOBAL MARKET STATISTICS
6.1.1.1 CARDIOVASCULAR DISEASES
6.1.2 DEVICES
6.1.3 APPS
6.1.4 KEY PLAYERS
6.2 DIABETES
6.2.1 DEVICES
6.2.2 APPS
6.2.3 KEY PLAYERS
6.3 RESPIRATORY
6.3.1 DEVICES
6.3.2 APPS
6.3.3 KEY PLAYERS
6.4 MENTAL AND NEUROLOGICAL DISORDERS
6.4.1 DEVICES
6.4.2 APPS
6.4.3 KEY PLAYERS
6.5 FITNESS & LIFESTYLE THERAPEUTICS
6.5.1 DEVICES
6.5.2 APPS
6.5.3 KEY PLAYERS
6.6 OTHERS
7 GLOBAL MHEALTHMARKET – APPLICATION/ SOLUTION TYPE
7.1 INTRODUCTION
7.1.1 MONITORING APPLICATIONS
7.1.1.1 KEY PARTICIPANTS
7.1.2 DIAGNOSIS & TREATMENT
7.1.2.1 KEY PARTICIPANTS
7.1.3 EDUCATION AND AWARENESS
7.1.3.1 KEY PARTICIPANTS
7.1.4 HEALTHCARE MANAGEMENT
7.1.5 WELLNESS & PREVENTION
7.1.6 OTHERS/ OTHER SERVICES AND APPLICATIONS MARKET
7.1.7 REMOTE DATA COLLECTION
7.1.7.1 KEY MARKET DEVELOPMENTS
8 GLOBAL MHEALTH MARKET–GEOGRAPHY
8.1 INTRODUCTION
8.1.1 MARKET STATISTICS
8.1.2 THE AMERICAS
8.1.3 NORTH AMERICA
8.1.3.1 THE U.S.
8.1.3.1.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.3.1.1.1 KEY MARKET TRENDS AND DEVELOPMENTS
8.1.3.1.1.2 KEY PARTICIPANTS
8.1.3.2 CANADA
8.1.3.2.1 KEY MARKET TREND
8.1.3.2.2 KEY PLAYERS
8.1.3.3 SOUTH AMERICA
8.1.3.3.1 CONSTRAINTS
8.1.3.3.2 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.3.3.2.1 MARKET TRENDS AND MARKET DEVELOPMENTS
8.1.3.3.2.2 KEY PARTICIPANTS
8.1.4 ASIA-PACIFIC (APAC)
8.1.4.1 KEY DRIVERS IN APAC
8.1.4.1.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.4.1.1.1 MARKET TRENDS & DEVELOPMENT
8.1.4.1.1.2 KEY PARTICIPANTS
8.1.4.2 CHINA
8.1.4.3 JAPAN
8.1.4.4 AUSTRALIA
8.1.4.5 INDIA
8.1.5 EUROPE
8.1.5.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.5.2 THE U.K.
8.1.5.3 GERMANY
8.1.5.4 KEY PARTICIPANTS
8.1.6 REST OF THE WORLD (ROW)
8.1.6.1 AFRICA
8.1.6.1.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.6.1.1.1 MARKET TRENDS AND MARKET DEVELOPMENTS
8.1.6.1.2 KEY PARTICIPANTS
8.1.7 MIDDLE EAST
8.1.7.1 KEY MARKET TRENDS, DEVELOPMENTS AND PARTICIPANTS
8.1.7.1.1 MARKET TRENDS AND MARKET DEVELOPMENTS
8.1.7.1.2 KEY PARTICIPANTS
9 KEY MARKET DEVELOPMENT AND STRATEGIES
9.1 INTRODUCTION
9.1.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
9.1.2 MERGERS & ACQUISITIONS
9.1.3 PRODUCT DEVELOPMENT AND LAUNCH
9.1.4 BUSINESS EXPANSION/CONTRACTS
9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS
9.1.6 OTHERS (EVENTS & RECOGNITIONS)
10 COMPANY PROFILES
1.1 AGAMATRIX, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 KEY DEVELOPMENTS
10.2 ALIVECOR, INC.
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 KEY DEVELOPMENTS
10.3 APPLE, INC.
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.2.1 OVERALL FINANCIALS
10.3.2.2 FINANCIALS BY SEGMENT
10.3.2.3 FINANCIALS BY REGION
10.3.2.4 FINANCIAL SUMMARY
10.3.3 KEY DEVELOPMENT
10.4 ATHENAHEALTH INC.
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.2.1 OVERALL FINANCIALS
10.4.2.2 FINANCIAL BY SEGMENTS
10.4.2.3 FINANCIAL SUMMARY
10.4.3 KEY DEVELOPMENT
10.5 AT&T, INC.
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.2.1 OVERALL FINANCIALS
10.5.2.2 FINANCIALS BY SEGMENT
10.5.2.3 FINANCIAL SUMMARY
10.5.3 KEY DEVELOPMENTS
10.6 BIOTELEMETRY, INC. (CARDIONET)
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.2.1 OVERALL FINANCIALS
10.6.2.2 FINANCIALS BY SEGMENT
10.6.2.3 FINANCIAL SUMMARY
10.6.3 KEY DEVELOPMENTS
10.7 GE HEALTHCARE
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.2.1 OVERALL FINANCIALS
10.7.2.2 FINANCIALS BY SEGMENT
10.7.2.3 FINANCIAL SUMMARY
10.7.3 KEY DEVELOPMENTS
10.8 GOOGLE INC.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.2.1 FINANCIAL SUMMARY
10.8.3 KEY DEVELOPMENTS
10.9 JAWBONE, INC.
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 KEY DEVELOPMENTS
10.1 JOHNSON & JOHNSON
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.2.1 OVERALL FINANCIALS
10.10.2.2 NET REVENUE BY SEGMENT
10.10.2.3 NET REVENUE BY REGION
10.10.3 KEY DEVELOPMENTS
10.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
10.11.1 OVERVIEW
10.11.2 FINANCIALS
10.11.2.1 OVERALL FINANCIALS
10.11.2.2 FINANCIALS BY SEGMENT
10.11.2.3 FINANCIAL SUMMARY
10.11.3 KEY DEVELOPMENTS
10.12 MEDTRONIC PLC
10.12.1 OVERVIEW
10.12.2 FINANCIALS
10.12.2.1 OVERALL FINANCIALS
10.12.2.2 FINANCIAL SUMMARY
10.12.3 KEY DEVELOPMENTS
10.13 NIKE INC.
10.13.1 OVERVIEW
10.13.2 FINANCIALS
10.13.2.1 OVERALL FINANCIALS
10.13.2.2 FINANCIALS BY SEGMENTS
10.13.2.3 FINANCIAL SUMMARY
10.13.3 KEY DEVELOPMENTS
10.14 PFIZER
10.14.1 OVERVIEW
10.14.2 FINANCIALS
10.14.2.1 OVERALL FINANCIALS
10.14.2.2 FINANCIALS BY SEGMENT
10.14.2.3 FINANCIALS BY REGION
10.14.2.4 FINANCIAL SUMMARY
10.14.3 KEY DEVELOPMENTS
10.15 PHILIPS HEALTHCARE
10.15.1 OVERVIEW
10.15.2 FINANCIALS
10.15.2.1 OVERALL FINANCIALS
10.15.2.2 FINANCIALS BY REGION
10.15.2.3 FINANCIALS BY SEGMENT
10.15.2.4 FINANCIAL SUMMARY
10.15.3 KEY DEVELOPMENTS
10.16 QUALCOMM, INC.
10.16.1 OVERVIEW
10.16.2 FINANCIALS
10.16.2.1 OVERALL FINANCIALS
10.16.2.2 FINANCIALS BY SEGMENT
10.16.2.3 FINANCIALS BY REGION
10.16.2.4 FINANCIAL SUMMARY
10.16.3 KEY DEVELOPMENTS
10.17 QUEST DIAGNOSTICS INC.
10.17.1 OVERVIEW
10.17.2 FINANCIALS
10.17.2.1 OVERALL FINANCIALS
10.17.2.2 FINANCIALS BY SEGMENT
10.17.2.3 FINANCIAL SUMMARY
10.17.3 KEY DEVELOPMENTS
10.18 ROCHE HOLDING AG-BR
10.18.1 OVERVIEW
10.18.2 FINANCIALS
10.18.2.1 OVERALL FINANCIALS
10.18.2.2 FINANCIALS BY SEGMENT
10.18.2.3 FINANCIAL SUMMARY
10.18.3 KEY DEVELOPMENTS
10.19 SAMSUNG ELECTRONICS CO. LTD.
10.19.1 OVERVIEW
10.19.2 FINANCIALS
10.19.2.1 OVERALL FINANCIALS
10.19.2.2 FINANCIAL SUMMARY
10.19.3 KEY DEVELOPMENTS
10.2 SANOFI PHARMA
10.20.1 OVERVIEW
10.20.2 FINANCIALS
10.20.2.1 OVERALL FINANCIALS
10.20.3 FINANCIALS BY SEGMENT
10.20.4 FINANCIAL SUMMARY
10.20.5 KEY DEVELOPMENTS
10.21 WITHINGS SAS
10.21.1 OVERVIEW
10.21.2 FINANCIALS
10.21.3 KEY DEVELOPMENTS
LIST OF TABLES
TABLE 1 LEADING COMPANIES IN THE MHEALTH MARKET
TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015)
TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS
TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM
TABLE 5 CONSORTIUMS IN MHEALTH MARKET
TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET
TABLE 7 REGULATORY BODIES IN MHEALTH MARKET
TABLE 8 MHEALTH MARKET CERTIFICATIONS
TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER
TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER
TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE
TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT
TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION
TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-2022 ($MILLION)
TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-2022 ($MILLION)
TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
TABLE 19 KEY DEVELOPMENTS
TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS
TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT
TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 25 TYPE OF APP
TABLE 26 KEY DEVELOPMENTS
TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 29 KEY DEVELOPMENTS
TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 42 REMOTE MONITORING IN GEOGRAPHIES
TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES
TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES
TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES
TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES
TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 62 MHEALTH: KEY DEVELOPMENTS (2011- 2015)
TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014
